Shows / Lung Cancer Considered
Lung Cancer Considered
Dr. Stephen Liu and Dr. Narjust Florez host Lung Cancer Considered, the podcast of The International Association for the Study of Lung Cancer (IASLC). IASLC is the only global organization dedicated solely to the study of lung cancer and other thoracic malignancies. Founded in 1974, the association's membership includes more than 11,000 lung cancer specialists across all disciplines in over 100 countries, forming a global network working together to conquer lung and thoracic cancers worldwide…
The show, from its episodes
No episode notes yet. Recurring topics, people and starter picks will appear when notes are available.
Typical episode length
39m · median of 425 episodes with a known length
Solo / guest format
Unknown — existing notes name people mentioned, but do not identify hosts or guests.
Recurring topics
No recurring topics established yet.
Recurring people
No recurring people established yet.
Start here
No starter picks yet — no published episodes with audio and a recorded notes hook.
Episodes
Lung Cancer ConsideredLCC in Korean: 2024 Lung Cancer Updates
LCC in Korean: 2024 Lung Cancer Updates by IASLC
Lung Cancer ConsideredLCC in Mandarin: Virtual Tumor Board - EGFR NSCLC
LCC in Mandarin: Virtual Tumor Board - EGFR NSCLC by IASLC
Lung Cancer ConsideredThe Microbiome and Immunotherapy for Lung Cancer
The Microbiome and Immunotherapy for Lung Cancer by IASLC
Lung Cancer ConsideredVirtual Tumor Board: Targeting Residual Disease
Virtual Tumor Board: Targeting Residual Disease by IASLC
Lung Cancer ConsideredLive from TTLC25: Lung Cancer and Brain Metastasis
Live from TTLC25: Lung Cancer and Brain Metastasis by IASLC
Lung Cancer ConsideredLung Cancer Considered in Turkish: First-Line Therapies in EGFR Mutant NSCLC
Host: Ece Cali Daylan, Assistant Professor of Medicine, Division of Oncology at Washington University School of Medicine Guest: Saadettin Kilickap Guest: Ozden…
Lung Cancer ConsideredThymus Talk: Unraveling Thymoma and Thymic Carcinoma
This episode of Lung Cancer Considered takes an in-depth look at thymoma and thymic carcinomas, both challenging diseases to treat with evolving new…
Lung Cancer ConsideredLung Cancer Considered in Hungarian: Lung Cancer Treatment Updates
As part of IASLC's ongoing series of podcasts in world languages, Dr. Balazs Halmos moderates a discussion in Hungarian with Dr. Krisztina Bogos, Dr. Ferenc…
Lung Cancer ConsideredLCC in Cantonese: WCLC24 Highlights
The 2024 World Conference on Lung Cancer brought together leading experts, researchers, and oncologists to showcase the latest advancements in lung cancer…
Lung Cancer ConsideredVirtual Tumor Board: Stage III ALK+ NSCLC
Virtual Tumor Board: Stage III ALK+ NSCLC by IASLC
Lung Cancer ConsideredLive from TTLC25: Targeted Therapy in Early Stage NSCLC Debate
Live from TTLC25: Targeted Therapy in Early Stage NSCLC Debate by IASLC
Lung Cancer ConsideredThe Benefits of Patient Advocacy Groups
In this episode of Lung Cancer Considered, host Dr. Narjust Florez engages in a discussion with patient advocate Summer Farmen. Listen to the episode to learn…
Lung Cancer ConsideredLive from TTLC 2025: Mesothelioma and NUT Carcinoma
In this episode of Lung Cancer Considered, host Dr. Narjust Florez leads a discussion of two of the most challenging thoracic malignancies – NUT carcinoma and…
Lung Cancer ConsideredLive from TTLC25: Targeted Therapy in SCLC
In this episode of Lung Cancer Considered, host Dr. Narjust Florez leads a discussion on how small cell lung cancer continues to evolve with new treatment…
Lung Cancer ConsideredLCC in Arabic: Chemo Immunotherapy in Metastatic NSCLC
Descriptions: As part of the IASLC's ongoing series of podcasts in world languages, Dr. Nagla Abdel Karim moderates a discussion in Arabic with Dr. Bashir Abu…
Lung Cancer ConsideredVirtual Tumor Board: Treating EGFR NSCLC After TKI Resistance
In this episode of Lung Cancer Considered, host Dr. Stephen Liu moderates a Virtual Tumor Board case involving drug resistance in EGFR mutant NSCLC. This…
Lung Cancer ConsideredLAURA Study (Part 2) - Radiation Oncology Perspective
This episode of Lung Cancer Considered covers the recent FDA approval of Osimertinib after chemo-radiation in EGFR positive NSCLC based on the LAURA trial…
Lung Cancer ConsideredLung Cancer in Mexico: Perspectives from the North and Ciudad de Mexico
En este episodio de Lung Cancer Considered, vamos a hablar sobre el cancer de pulmón en México. Tengo el placer de tener en este episodio dos doctores con…
Lung Cancer ConsideredIASLC Lung Cancer Considered in German
Description: As part of IASLC’s commitment to communicating in all world languages, this episode of Lung Cancer Considered is recorded in German and is part of…
Lung Cancer ConsideredFDA Approval Zenocutuzumab For NRG1 Fusion Cancers
In this episode of Lung Cancer Considered, host Dr. Stephen Liu discusses the recent FDA approval of zenocutuzumab for NSCLC with an NRG1 fusion. NRG1 fusions…
Lung Cancer ConsideredESMO Immuno-Oncology Congress 2024 Highlights
ESMO Immuno-Oncology Congress 2024 Highlights Description: In this episode of Lung Cancer Considered, host Dr. Narjust Florez and Dr. Alfredo Addeo discuss…
Lung Cancer Considered2025 Pan-Africa Conference on Lung Cancer Meeting Preview
Preview: 2025 Pan-Africa Lung Cancer Meeting The 2025 Pan-Africa Lung Cancer Conference will take place January 31 - February 1, 2025, in Accra, Ghana and…
Lung Cancer ConsideredIASLC Lung Cancer Considered: ESMO Asia 2024 Highlights
Lung Cancer Considered host Dr. Stephen Liu and two distinguished thoracic oncologists review the highlights from the recently completed ESMO Asia 2024…
Lung Cancer ConsideredFDA Approval: TT Fields for NSCLC
Tumor Treating Fields (TTFields) is a non-invasive cancer treatment that uses alternating electric fields to disrupt the ability of cancer cells to divide…
Lung Cancer ConsideredFDA Approval: Perioperative Nivolumab + Chemotherapy - CheckMate 77T
In this episode of Lung Cancer Considered, host Dr. Stephen Liu leads a discussion on the FDA approval of perioperative nivolumab based on the Phase III…
Lung Cancer ConsideredLALCA Episode in English
In this episode of Lung Cancer Considered host Dr. Narjust Florez discusses the future of lung cancer research in Brazil and the largest lung cancer screening…

Lung Cancer ConsideredLALCA Highlights in Spanish
Description: Join us for an engaging discussion on groundbreaking research from investigators across Latin America, featuring insights from large lung cancer…
Lung Cancer ConsideredLAURA Trial Part 1
Lung Cancer Considered host Dr. Narjust Florez and Dr. Suresh Ramalingam discuss the recent FDA approval of osimertinib after chemo-radiation in EGFR positive…
Lung Cancer ConsideredNinth Edition of Tumor, Node and Metastasis (TNM) Classification System
In this episode of Lung Cancer Considered, host Dr. Stephen Liu and guests preview the publication of the Ninth Edition of Tumor, Node and Metastasis (TNM)…
Lung Cancer ConsideredLung Cancer Considered--The Year in Review
Lung cancer breakthroughs, practice updates, and key meetings made 2024 one of the most consequential years in recent memory for lung cancer researchers and…
Lung Cancer ConsideredLCC in Hindi: Contemporary Issues in Lung Cancer Care
In this episode of Lung Cancer Considered, Dr. Aakash Desai moderates a discussion in Hindi on management of non-small cell lung cancer and small cell lung…
Lung Cancer ConsideredVirtual Tumor Board_Metastatic Squamous NSCLC
Description: In this virtual tumor board episode of Lung Cancer Considered, host Dr. Stephen Liu leads a discussion on the management of a patient with…
Lung Cancer ConsideredVirtual Tumor Board: Pregnancy
Description: As the incidence of lung cancer in those under age 35 increases, oncologists are finding that pregnancy is a central issue for many young women…
Lung Cancer ConsideredIASLC - Exercise And Lung Cancer
The Power of Movement: Exercise and Lung Cancer-- a Conversation with Experts Description: In this episode of Lung Cancer Considered, host Dr. Narjust Florez…
Lung Cancer ConsideredIASLC - Hot Topic Meeting On Tolerance And Resistance To Targeted Therapy In NSCLC 2
Title: IASLC Hot Topic Meeting on Tolerance and Resistance to Targeted Therapy in NSCLC (recorded on 10/21) Description: In this episode of Lung Cancer…
Lung Cancer ConsideredLCC in Arabic: Training and Education in Medical Oncology and Lung Cancer
As part of the IASLC's ongoing series of podcasts in world languages, this episode brings together two leading lung cancer experts who discuss training and…
Lung Cancer ConsideredIASLC Virtual Tumor Board Relapsed SCLC
In this episode of Lung Cancer Considered, host Dr. Stephen Liu moderates a discussion about the management of relapsed SCLC, which remains a very challenging…
Lung Cancer ConsideredLung Cancer Considered--Managing ADC Toxicities
Lung Cancer Considered--Managing ADC Toxicities by IASLC
Lung Cancer ConsideredLCC in Arabic: WCLC 2024 Highlights
The 2024 World Conference on Lung Cancer brings together leading experts, researchers, and oncologists to showcase the latest advancements in lung cancer…
Lung Cancer ConsideredIASLC LALCA Preview (in Spanish)
Host Dr. Narjust Florez previews the 2024 Latin America Lung Cancer Meeting with co-chairs Dr. Lucia Viola, Dr. Andres Feliple Cardona and Dr. Stella Martinez…
Lung Cancer ConsideredESMO 2024 Highlights
This episode of Lung Cancer Considered covers the recently completed 2024 ESMO Congress in Barcelona. Host Dr. Stephen Liu discussed the important research…
Lung Cancer ConsideredFDA Approval: KEYNOTE 483, Pembrolizumab plus Chemotherapy for Mesothelioma
In a special episode of Lung Cancer Considered, host Dr. Stephen Liu discuss the recent FDA approval of pembrolizumab plus platinum and pemetrexed for…
Lung Cancer ConsideredIASLC - ACLC 2024 Preview
In this episode of Lung Cancer Consider, host Dr. Stephen Liu previews the upcoming IASLC 2024 Asia Conference on Lung Cancer with meeting co-chair, Dr…
Lung Cancer ConsideredFDA Approval: MARIPOSA2, Amivantamab plus Chemotherapy after Osimertinib for EGFR NSCLC
Description: The FDA approved amivantamab therapy for EGFR mutant NSCLC after progression on osimertinib. This approval is based on the phase III MARIPOSA-2…
Lung Cancer ConsideredLCC in Portuguese: WCLC 2024 Highlights
The 2024 World Conference on Lung Cancer brings together leading experts, researchers, and oncologists to showcase the latest advancements in lung cancer…
Lung Cancer ConsideredLive From WCLC 2024: Nurse Practitioner Highlights
In this special episode of Lung Cancer Considered, Stephanie McDonald and Jillian Thompson discuss their perspectives of attending the 2024 World Conference on…
Lung Cancer ConsideredLCC in Spanish: WCLC 2024 Highlights
The 2024 World Conference on Lung Cancer brings together leading experts, researchers, and oncologists to showcase the latest advancements in lung cancer…
Lung Cancer ConsideredLive From WCLC 2024: Meeting Summary
In this special WCLC 2024 episode of Lung Cancer Considered, hosts Dr. Narjust Florez and Dr. Stephen Liu recap the conference and discuss the meeting's most…
Lung Cancer ConsideredLCC in Mandarin: WCLC 2024 Highlights
The 2024 World Conference on Lung Cancer brings together leading experts, researchers, and oncologists to showcase the latest advancements in lung cancer…
Lung Cancer ConsideredLive From WCLC 2024: Monday Highlights
In this special WCLC 2024 episode of Lung Cancer Considered, host Dr. Narjust Florez discusses daily highlights from the conference. Dr. Xiuning Le reports…
Lung Cancer ConsideredLCC in Korean: WCLC 2024 Highlights
The 2024 World Conference on Lung Cancer brings together leading experts, researchers, and oncologists to showcase the latest advancements in lung cancer…
Lung Cancer ConsideredLive From WCLC 2024: Sunday Highlights
In this special WCLC 2024 episode of Lung Cancer Considered, host Dr. Stephen Liu discusses daily highlights from the conference. Dr. Caicun Zhou discusses the…
Lung Cancer ConsideredWith Eyes On The Future IASLC 50th Anniversary
Description: To celebrate IASLC’s 50th Anniversary, IASLC produced podcasts looking at our past and present. In this podcast, host Dr. Narjust Florez peers…
Lung Cancer ConsideredIASLC's 50th Anniversary: The IASLC Today
Description: This year marks the 50th anniversary of the International Association for the Study of Lung Cancer and as part of this celebratory year, we are…
Lung Cancer ConsideredIASLC - The First Decade
In 1972, in response to the overwhelming need for collaboration and a growing concern for public health, Drs. David T. Carr, Oleg S. Selawry, Lawrence Broder…
Lung Cancer ConsideredFDA Approval: MARIPOSA, First-Line Amivantamab plus Lazertinib for EGFR NSCLC
Description: On August 19th, the Food and Drug Administration approved lazertinib in combination with amivantamab for the first-line treatment of locally…
Lung Cancer ConsideredLCC In Mandarin
As part of IALC's ongoing series of podcasts in world languages, this podcast brings together four of the leading Chinese lung cancer experts who discuss…
Lung Cancer ConsideredIASLC - WCLC 2024 Preview
Description: In this episode of Lung Cancer Considered, host (and WCLC 2024 Co-Chair) Dr. Narjust Florez previews the upcoming IASLC 2024 World Conference on…
Lung Cancer ConsideredIASLC - Spanish Episode Neoadjuvant Therapies In NSCLC
In this episode of Lung Cancer Considered, host Dr. Narjust Florez moderates a discussion in Spanish about perioperative chemotherapy and immunotherapy and how…